Posts Tagged Medical Center

Strong Memorial Hospital earned a perfect score on the annual survey conducted by the Human Rights Campaign Foundation. The survey evaluates inclusive policies and practices related to LGBTQ patients, visitors, and health care employees.

The new drug, Dupilumab, is the first treatment to show significant, lasting results for adults with eczema. The FDA approval is a “game-changer,” says Lisa Beck, professor of dermatology who led three years of clinical trials.

A computer model to help clinicians predict Parkinson’s disease progression has landed two Rochester undergraduates and their faculty mentor a top honor from the Michael J. Fox Foundation.

Stephen Sulkes, a professor at Golisano Children’s Hospital and co-director of the Strong Center for Developmental Disabilities, was honored for his work encouraging students to get involved with Special Olympics.

Ajay Kuriyan, an assistant professor of ophthalmology at the Medical Center, cautions against what can go wrong when stem cell procedures are not appropriately regulated.

The label may say “cinnamon” or “vanilla” but the true contents of e-cigarette flavorings are acetoin, diacetyl, and other additives known to irritate the respiratory tract and impair lung function, according to a collaborative study from western New York scientists.

A new study shows that a drug developed at the Medical Center extends the effectiveness of multiple HIV therapies, and could lead the way to long-acting HIV drugs that could be administered once or twice per year, rather than daily.

The grant from the Centers for Disease Control and Prevention renews the University’s role as a member of the Emerging Infections Program, a national network that monitors several infectious threats and conducts studies that guide policy related to prevention and treatment.

A new study from researchers at the UR Medicine Sports Concussion Clinic suggests that elevated levels of the brain protein tau may serve as a marker to help physicians determine an athlete’s readiness to return to the game.

Researchers at the University’s Wilmot Cancer Institute and Roswell Park in Buffalo have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of four genes.